Abstract:Kai Wu, 1, * Qiong Feng, 2, * Liang Li, 1 Yanfei Xiong, 3 Shihong Liu, 4 Jie Liu, 1 Qing Wu 1 1 Department of Orthopedics, The Second Affiliated Hospital of Nanchang University, Nanchang 300006, People's Republic of China; 2 Nursing School, Nanchang University, Nanchang 300006, People's Republic of China; 3 Department of Orthopedics, Jingan Hospital, Yichun 330600, People's Republic of China; 4 Jingan Hospital of Traditional Chinese Medicine, Yichun 330600, People's Republic of China *These authors contributed equally to this work Correspondence: Qing Wu Email wuqing18186@126.com Introduction: The long-noncoding RNA PCAT6 plays an important regulatory role in the development of several cancers. However, the expression pattern and underlying mechanisms of PCAT6 in osteosarcoma (OS) are yet unknown. Methods: We used real-time PCR to measure PCAT6 expression in 106 tumor pairs and corresponding non-tumor tissues from OS patients. Statistical analyses were applied to evaluate the prognostic value and associations of PCAT6 expression with clinical parameters. Furthermore, the PCAT6 was silenced with siRNA in OS cells. Moreover, phenotype of PCAT6 silenced OS cells was measured using colony formation, CCK-8, cell migration and invasion assay. Finally, the molecular mechanism of PCAT6/miR-143-3p/ZEB1 axis in OS progression was explored. Results: The expression level of PCAT6 in OS tissues was significantly elevated as compared with that in the adjacent normal bone tissues and that high PCAT6 expression closely correlated with the malignant phenotype and poor survival among patients with OS. Multivariate analyses revealed PCAT6 overexpression as an independent prognostic factor for the poor outcome of patients with OS. Functional assay results demonstrated that the knockdown of PCAT6 expression notably suppressed the proliferation, migration, and invasion of OS cells. An elevated PCAT6 level aggravated the malignant phenotype of OS cells via ZEB1 expression upregulation. Mechanistic studies revealed that PCAT6 could sponge endogenous miR-143-3p and inhibit its activity, resulting in an increase in ZEB1 level. Finally, we demonstrated that the tumour-promoting role of PCAT6 in OS was dependent on the regulation of the miR-143-3p/ZEB1 axis. Conclusion: These findings highlight the potential role of PCAT6, which could serve as a valuable prognostic indicator for patients with OS. Keywords: osteosarcoma, PCAT6, ZEB1, miR-143-3p

The CtIP-CtBP1/2-HDAC1-AP1 transcriptional complex is required for the transrepression of DNA damage modulators in the pathogenesis of osteosarcoma

Zinc finger Asp-His-His-Cys palmitoyl -acyltransferase 19 accelerates tumor progression through wnt/β-catenin pathway and is upregulated by miR-940 in osteosarcoma

Overexpression of HIPK2 Removes the Transrepression of Proapoptotic Genes Mediated by the CtBP1-p300-FOXO3a Complex and Increases the Chemosensitivity in Osteosarcoma Cells.

Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Targeting the CtBP1-FOXM1 transcriptional complex with small molecules to overcome MDR1-mediated chemoresistance in osteosarcoma cancer stem cells

Figure S5 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Histone demethylase KDM5A promotes tumorigenesis of osteosarcoma tumor

HMGB1 Promotes Cellular Proliferation and Invasion, Suppresses Cellular Apoptosis in Osteosarcoma

CtBP1/2 Differentially Regulate Genomic Stability and DNA Repair Pathway in High-Grade Serous Ovarian Cancer Cell

The Sp1/FOXC1/HOTTIP/LATS2/YAP/β‐catenin Cascade Promotes Malignant and Metastatic Progression of Osteosarcoma

Minichromosome Maintenance Protein 2 and 3 Promote Osteosarcoma Progression Via Dhx9 and Predict Poor Patient Prognosis

DNA Methylation is Involved in the Pathogenesis of Osteoarthritis by Regulating CtBP Expression and CtBP-mediated Signaling.

Expression and Prognostic Value of MCM Family Genes in Osteosarcoma

DownRegulated SOX4 Expression Suppresses Cell Proliferation, Migration, and Induces Apoptosis in Osteosarcoma In Vitro and In Vivo

Downregulation of Cdc6 Inhibits Tumorigenesis of Osteosarcoma in Vivo and in Vitro.

DNMT1 determines osteosarcoma cell resistance to apoptosis by associatively modulating DNA and mRNA cytosine-5 methylation

Suppressing CHD1L Reduces the Proliferation and Chemoresistance in Osteosarcoma.

Hmgb1 Promotes Drug Resistance In Osteosarcoma

Targeting the CK1α/CBX4 Axis for Metastasis in Osteosarcoma.

Long-Noncoding RNA PCAT6 Aggravates Osteosarcoma Tumourigenesis via the MiR-143-3p/ZEB1 Axis

Molecular Regulation Mechanism of COPB2 Gene on Human Osteosarcoma Cell Based on Ingenuity Pathway Analysis